logo
How Trump's Travel Ban And Visa Restrictions Could Affect Hospitals And Public Health

How Trump's Travel Ban And Visa Restrictions Could Affect Hospitals And Public Health

Forbes11 hours ago
WASHINGTON, DC - JUNE 26: A man bearing an upside down American flag watches as protesters gather ... More outside the U.S. Supreme Court as the court issued an immigration ruling June 26, 2018 in Washington, DC. The court issued a 5-4 ruling upholding the Trump administration's policy imposing limits on travel from several primarily Muslim nations. (Photo by)
Several hospitals throughout the country are currently without some international medical graduates (IMG) because of President Trump's travel band and visa restrictions.
According to the travel ban, citizens from 12 foreign countries are barred from entering the United States, and citizens from seven other countries will also face restrictions, making it difficult for many doctors who have completed medical education in foreign countries to train in America. In addition, on May 27th, the Trump administration restricted certain visas like J-1 visas from being issued which allow foreign medical students to work and train in the United States. The pause on interviews for J-1 visas has since been lifted, but some IMGs have reported to the Associated Press that U.S. embassies have been slow to open interview slots, and some have not opened any.
This comes at a critical time, since July 1st marked the first calendar day of medical residencies or training programs throughout the U.S. On July 1st, newly graduated medical students start medical training in their prospective fields such as internal medicine, emergency medicine and surgery; to name a few.
Although it remains unclear exactly how many IMGs have had their residency start date delayed due to the travel ban or visa restrictions, nearly 7,000 foreign born IMGs matched or filled into U.S. programs in 2025. This represents nearly 17% of the entire incoming workforce of medical residents in 2025, according to the National Resident Matching Program.
Without IMGs joining the medical workforce in America, the physician shortage will be exacerbated for the next decade. In fact, the U.S. will face a physician shortage of 86,000 doctors by 2036, according to the Association of American Medical Colleges. Less physicians means longer wait times in emergency rooms, delayed diagnoses and significant strain on safety-net hospitals. IMGs make up a critical component of the healthcare workforce, and without them, patient care is directly compromised.
IMGs also choose residencies and take jobs in places where U.S. medical trainees tend not to go, according to National Resident Matching Program President Donna Lamb, as reported by the Associated Press. As an example, IMGs make up 40% of residents in internal medicine, a primary care field with a focus on preventing chronic conditions like diabetes, cancer and heart disease.
In addition, IMGs play a critical role in serving underserved areas throughout America, providing primary care, cancer screening and emergency care to some of the U.S.'s most vulnerable population. According to a 2021 study published in Journal of Community Hospital Internal Medicine Perspectives, more than 64% of IMGs surveyed practiced in medically underserved areas and more than 45% practiced in rural areas. These foreign-grad doctors form the backbone of healthcare in rural America, and without them, the health of the 66 million Americans that are served by rural hospitals could be in jeopardy.
Finally, Trump's travel ban could have a chilling effect on future foreign medical applicants to the U.S. Prospective physicians may be deterred from considering medical training programs in America given the challenges and hurdles present in securing visas. Not only will this amplify the physician shortage in the U.S., it will decrease the amount of culturally competent physicians that serve an increasingly diverse population in America.
President Trump's travel ban, which has been enacted in the name of national security and public safety, could have serious consequences for public health and medical education. One thing remains certain- IMGs form a vital part of the healthcare workforce in the United States.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The Gas Station Chain That Offers Frozen House-Made Energy Drinks
The Gas Station Chain That Offers Frozen House-Made Energy Drinks

Yahoo

time33 minutes ago

  • Yahoo

The Gas Station Chain That Offers Frozen House-Made Energy Drinks

It seems like everyone's gotten into the energy drink market these days, from Monster, Ghost, and Celsius, to the OG, Red Bull. Some might say that the market is oversaturated, but Wawa saw that market share and asked, "What if energy drinks could also be slushies?" And thus, it created Rechargers. These brightly-colored, frozen, house-made energy drinks are perfect for those times when you can't decide between a frozen margarita and a Mountain Dew Kickstart. Because really, you shouldn't have to as long as you're near a Wawa. If you're not from the Mid-Atlantic or lower East Coast area of the U.S., you might not know that Wawa, a beloved convenience store, is much more than a simple gas station. From fresh house-brand coffee to substantial made-to-order meatball hoagies, Wawa truly walks the line between convenience store and café, and its line of energy drinks, which were released in 2023, are another fan favorite on its lengthy lineup of road-ready offerings. What sets Wawa's line of drinks apart from, say, a typical can of Bang, where every sip is identical, is that the chain offers what seems like endless ways to customize your drink. Read more: Store-Bought Lemonade, Ranked From Worst To Best Energy drink lovers know that no matter the brand, the flavors can leave a lot to be desired. Even if you've grown to love the medicinal taste of Red Bull, there's no denying that it's nice to have some flavor options to mask the taste of caffeine and supplements like taurine, B vitamins, and ginseng. This is where Wawa's Rechargables really come in clutch. You can choose from more than 10 different base flavors like Sunset Punch (mango lemonade), or The Mermaid (blue raspberry, passionfruit, and dragonfruit). Each drink comes standard with 75 to 150 milligrams of caffeine, with an option to add a "boost" of energy (an additional 37 to 111 milligrams of caffeine), immunity (vitamins and minerals including vitamin C, vitamin D, vitamin B3, and zinc), or protein (100% whey). You can also add Sour Cherry Popping Bubbles for an extra fee. In addition to sizing (16 to 32 ounces), your drink can be served iced instead of frozen, and there are options for less sugar or zero sugar. Admittedly, it is all a lot of decision making, and you need to keep your wits about you to order a soft pretzel, a delicacy in Eastern Pennsylvania, so once you've figured out your ideal Recharger combo, be sure to save it as a favorite in the Wawa app so that ordering a little get-up-and-go is that much easier next time. Read the original article on Chowhound.

Trump hits out at Musk over plan to form new political party
Trump hits out at Musk over plan to form new political party

Yahoo

time38 minutes ago

  • Yahoo

Trump hits out at Musk over plan to form new political party

US President Donald Trump has hit out at former close ally Elon Musk over the multi-billionaire's plan to launch a new political party. "I am saddened to watch Elon Musk go completely 'off the rails,' essentially becoming a train wreck over the past five weeks," Trump posted on his Truth Social platform on Sunday. After teasing the idea for weeks, Musk posted on X over the weekend that he had set up the America Party to compete against the Republican and Democratic parties. The Tesla boss's announcement comes weeks after a dramatic falling out with Trump, who appointed Musk to lead the Department of Government Efficiency (Doge), which is tasked with identifying areas to cut federal spending. In his post, Trump also took aim at Musk's push for an "Electric Vehicle (EV) Mandate", saying it would have "forced everyone to buy an electric car in a short period of time." Trump's tax and spending plans - which he called his "big, beautiful bill" - ends tax breaks for electric vehicles.

Abinopharm, Inc. and EGT Synbio Announce Successful Human Clinical Trials on Oral L-Ergothioneine (Dr.Ergo®) for Skin Health
Abinopharm, Inc. and EGT Synbio Announce Successful Human Clinical Trials on Oral L-Ergothioneine (Dr.Ergo®) for Skin Health

Yahoo

time38 minutes ago

  • Yahoo

Abinopharm, Inc. and EGT Synbio Announce Successful Human Clinical Trials on Oral L-Ergothioneine (Dr.Ergo®) for Skin Health

SHELTON, Conn., July 06, 2025 (GLOBE NEWSWIRE) -- Abinopharm, Inc., an innovative nutritional and biopharmaceutical company based in Shelton, Connecticut, USA, is pleased to announce that its partner, EGT Synbio, headquartered in Shanghai, China, has successfully completed two human clinical trials evaluating the effects of oral L-ergothioneine ( on skin health. Abinopharm, Inc. is the exclusive U.S. collaborator and distributor for EGT Synbio's premium L-ergothioneine product, L-Ergothioneine was first isolated in 1909 by French chemist Charles Tanret from the ergot fungus (Claviceps purpurea), giving the compound its name: 'ergo' from ergot and 'thioneine' denoting a sulfur-containing compound. Although ergothioneine is found in many plants and animals, it cannot be synthesized by them and must be acquired from fungi—especially mushrooms—and certain bacteria. In humans, dietary intake of mushrooms, particularly shiitake, maitake, and oyster mushrooms, which contain 10–13 mg/100 g dry weight, is the main source. For many years, the biological significance of ergothioneine remained obscure. This changed in 2005 when Professor Günther Gündemann discovered the ergothioneine-specific transporter OCTN1 (SLC22A4), which facilitates its accumulation in nearly all human tissues, particularly in the bone marrow, liver, kidneys, red blood cells, brain, eyes, and skin. Professor Barry Halliwell, a pioneer in the study of reactive oxygen species (ROS) and oxidative stress, later identified ergothioneine as one of the most potent natural antioxidants. He demonstrated its role in mitigating oxidative damage and inflammation—factors contributing to conditions such as neurodegenerative diseases (e.g., Alzheimer's, Parkinson's), cardiovascular disorders, and liver disease. Studies have also shown that ergothioneine has high bioavailability, a long half-life in the human body, and offers cellular protection—particularly within mitochondria—thereby helping maintain cognitive function, reduce inflammation, and support healthy longevity. In 2018, renowned biochemist Professor Bruce Ames proposed that ergothioneine be classified as a 'longevity vitamin'—a micronutrient not essential for immediate survival but vital for long-term health and healthy aging. He suggested that low levels of ergothioneine may accelerate aging and increase the risk of chronic diseases. A Nutrient for Radiant and Resilient Skin Ergothioneine is a multifunctional skincare nutrient known for its antioxidant power, anti-inflammatory effects, and UV protection. It protects skin cell components—lipids, DNA, and proteins—from oxidative damage and premature aging, helps prevent photoaging (e.g., sunspots, collagen breakdown), soothes redness and inflammation (e.g., acne, eczema, sensitive skin), promotes even skin tone and radiance, supports collagen synthesis and elasticity, and enhances skin hydration. While ergothioneine has been used topically in cosmetic products for years, a 2024 Japanese clinical study confirmed its effectiveness as an oral "beauty-from-within" ingredient. In this study, participants who consumed a hiratake (oyster mushroom) tablet containing 25 mg of ergothioneine daily experienced significant improvements in facial skin moisture and overall skin condition (Frontiers in Medicine, 2024). New Clinical Results with Abinopharm and EGT Synbio now report results from two human clinical trials evaluating the efficacy of L-ergothioneine for skin health: Open-label trial in China (2023):Nineteen healthy participants consumed 25 mg of daily for four weeks. Dermatological assessments using the VISIA imaging system revealed visible improvements in skin pores, wrinkles, UV spots, brown spots, and porphyrins. No adverse effects were reported. Results were published in the American Journal of Biomedical Science & Research (DOI: 10.34297/AJBSR.2023.20.002779). Double-blind, placebo-controlled trial in Japan (2024):Conducted by the Japan Clinical Trial Association (JACTA), this 8-week study enrolled 66 healthy women aged 35 to 59. Participants received 30 mg of daily. Skin parameters including brightness, tone, melanin, erythema, gloss, elasticity, and spots were measured using scientific instruments and questionnaires. After 8 weeks, participants showed statistically significant improvements (p < 0.01) in brightness, elasticity, melanin levels, erythema, wrinkles, and skin gloss. No significant adverse events were reported. Details available at - and Safety Commitment is produced using a patented full enzymatic fermentation process (EP 4520819A1) under strict cGMP standards. It has been granted (Generally Recognized as Safe) status, NSF GMP certification, HACCP compliance, and HALAL certification. The product adheres to ICH quality guidelines, with purity and optical purity >99.9%. All impurities, heavy metals, and microbial levels are controlled within USP limits. About EGT SynbioEGT Synbio pioneers biological solutions for anti-aging. Its scientific team develops clinically validated compounds, including the premium L-Ergothioneine—an odorless, stable crystal ingredient used by global brands and certified by U.S. GRAS, EU Novel Food, and NSF. In 2024, EGT Synbio launched EquoPro™ (S)-Equol and Spermidine Hydrochloride, expanding its offerings in dietary supplements, skincare, and pharmaceuticals. Its ingredients are now widely used across functional foods, luxury beauty, and medical-grade nutrition. About Abinopharm, Inc. is a U.S.-based nutritional and biopharmaceutical company focused on developing, manufacturing, and commercializing premium health products in the U.S. and globally. Its nutritional division specializes in longevity ingredients, partnering with leading academic and industry experts. The company's NMN ingredient (AbinoNutra®NMN) holds Self-Affirmed GRAS status and has been clinically validated in collaboration with Professor Andrea Maier. Other flagship ingredients include L-Ergothioneine ( Fisetin (BeFisetin®), Urolithin A, CaAKG, Spermidine ( S-Equol (EquoPro™), and Hydroxytyrosol. Abinopharm offers regulatory support (e.g., GRAS, NPN), as well as private-label solutions for supplements made in the U.S., Canada, and Europe. Contact:Public ServiceAbinopharm, A photo accompanying this announcement is available at in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store